{"id":"W2991616458","doi":"10.1093/annonc/mdz296","title":"EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Cilag; Pharmacyclics; Chugai Pharmaceutical; MSD Australia; EMD Serono; Genentech; Active Biotech; Medac; Ipsen; Bavarian Nordic; Shionogi; Astellas Pharma; Eisai; European Society for Medical Oncology; European Association of Urology; Sirtex Medical; Cancer Research UK; GlaxoSmithKline; UroGen Pharma; Pfizer; Incyte; Manchester Biomedical Research Centre; Accuray; National Institute for Health and Care Research; Clovis Oncology; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Celldex Therapeutics; Siemens Healthineers; Amgen; Elekta; Sanofi Pasteur; Royal Marsden NHS Foundation Trust; Alere; Bayer HealthCare; Exelixis; Sanofi; Endocyte; Novartis; Bayer; Allergan; AstraZeneca; Associazione Italiana per la Ricerca sul Cancro; Eli Lilly and Company","keywords":"Medicine; Delphi method; Stakeholder; Delphi; Bladder cancer; Voting; Consensus conference; Family medicine; Cancer; Public relations; Internal medicine; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003199475,0.0001470206,0.0003304366,0.00004140281,0.00006622423,0.000006778384,0.0001811591,0.00005939976,0.0001126061],"category_scores_gemma":[0.00001971105,0.00007066243,0.00004387539,0.0001143117,0.0003725808,0.00005382153,0.0001031626,0.00009682451,0.00000100658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002800571,"about_ca_system_score_gemma":0.0001442311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000779148,"about_ca_topic_score_gemma":0.0006531183,"domain_scores_codex":[0.998857,0.0001194261,0.0004125267,0.0002062909,0.000257511,0.000147253],"domain_scores_gemma":[0.9986037,0.0001879028,0.000376165,0.0003172789,0.0004763232,0.00003861968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01835901,0.008941478,0.5704621,0.001680249,0.03862452,0.0001256503,0.02929267,0.0075397,0.01379765,0.08296071,0.03070971,0.1975065],"study_design_scores_gemma":[0.01122912,0.004352849,0.9146419,0.0006011018,0.0006565717,0.00001423703,0.01684022,0.0006033287,0.01399838,0.001170752,0.03568428,0.0002073104],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9699375,0.0006763435,0.000009222681,0.025112,0.0003189992,0.001041957,0.0001734915,0.000004864809,0.002725589],"genre_scores_gemma":[0.9933047,0.001990763,0.0004465495,0.003356094,0.00002834225,0.00006210677,0.00000759479,0.00001218663,0.000791649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3441797,"threshold_uncertainty_score":0.288153,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1653293173419298,"score_gpt":0.4504202926011262,"score_spread":0.2850909752591964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}